Edick Paul R
- SEC CIK
- 0001531178
No open-market purchases or sales filed in the past year.
Current role at each company
- VTGN Vistagen Therapeutics, Inc.Directoras of Nov 4, 2025
- XERS Xeris Biopharma Holdings, Inc.See Remarksas of Jan 31, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Edick Paul R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XERS Xeris Biopharma Holdings, Inc.
See Remarks5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 (view filing) | Aug 9 | Same day | Edick Paul RSee Remarks | PPurchase | +10.0K | $2.38 | +$23.8K | +0.4%2.29M after | |
| Dec 14, 2022 (view filing) | Dec 13 | 1 day | Edick Paul RSee Remarks | PPurchase | +20.0K | $1.45 | +$29.0K | +1.3%1.53M after | |
| May 13, 2022 (view filing) | May 12 | 1 day | Edick Paul RSee Remarks | PPurchase | +100.0K | $1.40 | +$140.0K | +7.1%1.51M after | |
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Edick Paul RSee Remarks | PPurchase | +20.0K | $2.28 | +$45.6K | +148.9%33.4K after | |
| Nov 12, 2021 (view filing) | Nov 11 | 1 day | Edick Paul RSee Remarks | PPurchase | +200.0K | $2.08 | +$416.0K | +32.9%808.1K after |